Clinical Trials Logo

Diabetic Foot Ulcer clinical trials

View clinical trials related to Diabetic Foot Ulcer.

Filter by:

NCT ID: NCT04054804 Completed - Diabetic Foot Ulcer Clinical Trials

Digital Foot Check by Using the D-Foot, a New Software

D-Foot2019
Start date: September 16, 2019
Phase:
Study type: Observational

Patients with diabetes should be thoroughly examined before they are provided with insoles and shoes. In the study the feet are examined with the help of a new software, the D-Foot. D-Foot includes questions and surveys. The aim of the of the study is evaluate how the patients experience the visit at the department of Prosthetics & Orthotics based on the digital foot check.

NCT ID: NCT04025853 Completed - Diabetic Foot Ulcer Clinical Trials

Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis

Start date: June 2015
Phase:
Study type: Observational

The investigators plan to do a retrospective chart review of 500 patients admitted to the hospital between January 1, 2010 and December 31, 2015 with diabetic foot infections. The investigators will define a positive case of osteomyelitis as bone with positive bacterial cultures or histologic finding of acute or chronic osteomyelitis. Levels of inflammatory biomarkers (CRP, ESR) will be collected from the charts from the first time of diagnosis. Because wound healing, biomarker levels and resolution of infection are clearly affected by other factors such as demographics, medical/surgical history, social history, medications, laboratory results, peripheral arterial disease, wound severity, and treatment factors such as type of antibiotics, off-loading, debridement and vascular surgery interventions these will also be collected. The investigators will collect this clinical data for both cohorts.

NCT ID: NCT03998436 Completed - Diabetic Foot Ulcer Clinical Trials

Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers

Start date: December 26, 2018
Phase: Phase 3
Study type: Interventional

The purpose of the current Study is to determine the safety and effectiveness of Galnobax® plus Standard of Care versus only Standard of Care, in treating Diabetic Foot Ulcers (DFU). In addition, Study is designed to investigate the safety of Galnobax® vehicle for establishing non-deleterious effects of Vehicle on wound healing in the Subjects with DFU. The study is being conducted in 350 subjects being recruited in about 30 centers in India.

NCT ID: NCT03985306 Completed - Diabetic Foot Ulcer Clinical Trials

Treatment of Diabetic Foot Ulcers With Inforatio Technique to Promote Wound Healing

Start date: March 20, 2019
Phase: N/A
Study type: Interventional

This trial will examine the feasibility of conducting a definitive randomized clinical trial that tests whether inforatio technique will reduce time to healing of diabetic foot ulcers. Inforatio technique is a procedure where small punch biopsies are taken from the wound bed near the edge of the wound. With this technique, the investigators wish to initiate an acute inflammatory response that increases the generation of granulation tissue with subsequent healing by scar formation. Thus, the investigators hypothesize that inforatio technique will promote healing of diabetic foot ulcers. Based on clinical experience, the investigators have previously detected a reduction in time to healing as an unexpected effect when multiple punch biopsies are taken from the wound bed of diabetic foot ulcers. To the knowledge of the investigators, methods similar to the inforatio technique has not previously been studied.

NCT ID: NCT03978715 Completed - Diabetic Foot Ulcer Clinical Trials

The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates

Start date: April 14, 2021
Phase:
Study type: Observational

The investigators plan to do a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investigators will collect information on demographics, medical/surgical history, social history, medications, laboratory results, peripheral arterial disease, wound severity, and treatment factors such as type of antibiotics, off-loading, debridement, wound healing, surgery interventions, complications, recurrence, and history and physical characteristics and exam from inpatient and outpatient encounters. This will be identified by current procedural terminology (CPT) codes for foot and leg amputations, and lower extremity revascularization procedures. Clinic visits will be identified to podiatry/foot wound, vascular surgery, invasive cardiology, general surgery, and physical therapy wound care in addition to inpatient encounters of these patients to determine the full scope of care received and to compare resources utilization before and after implementation of the diabetic limb preservation team.

NCT ID: NCT03955289 Completed - Diabetic Foot Ulcer Clinical Trials

Treatment of Foot and Leg Ulcers Using a Laser

Start date: January 15, 2019
Phase:
Study type: Observational

The investigators plan to do a retrospective chart review on patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic.

NCT ID: NCT03939000 Completed - Clinical trials for Type 2 Diabetes Mellitus

Clinical Profile and Laboratory Finding of DFU From Tertiary Hospitals in Bali

Start date: March 2016
Phase:
Study type: Observational

The investigators want to obtain the clinical profile, hematological profile, and biochemical profile from diabetic foot ulcer (DFU) patient.

NCT ID: NCT03905863 Completed - Diabetic Foot Ulcer Clinical Trials

The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers

Start date: June 4, 2019
Phase: N/A
Study type: Interventional

A Multicentre Randomized Controlled Trial to Investigate the Effect of Natrox Topical Oxygen Wound Therapy on the Healing rates of Diabetic Foot Ulcers.

NCT ID: NCT03888053 Completed - Diabetic Foot Ulcer Clinical Trials

BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers

Start date: March 28, 2018
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, sequential dose escalation study in diabetic subjects with a diabetic lower leg or foot ulcer. All subjects will receive standard-of-care ulcer treatment from screening through the last study visit.

NCT ID: NCT03881254 Completed - Diabetic Foot Ulcer Clinical Trials

SkinTEā„¢ in the Treatment of Diabetic Foot Wounds

Start date: April 2, 2019
Phase: N/A
Study type: Interventional

This study is a prospective, multi-center, randomized controlled trial designed to collect patient outcome data on a commercially available human autologous homologous skin construct with SOC dressing compared to SOC dressings alone in the treatment of Diabetic Foot Wounds.